PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study.

Abstract This study was performed to evaluate the prevalence and clinical characteristics of dry eye disease (DED) in community-based type 2 diabetic patients and to identify the associated factors related with DED.
PMID
Related Publications

Corneal permeability changes in dry eye disease: an observational study.

Tear film function of patients with type 2 diabetes.

Prevalence of dry eye disease in an elderly Korean population.

Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients.

Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study.

Authors

Mayor MeshTerms
Keywords

Community-based

Dry eye disease

Prevalence

Type 2 diabetic patients

Journal Title bmc ophthalmology
Publication Year Start




PMID- 29747621
OWN - NLM
STAT- MEDLINE
DCOM- 20180525
LR  - 20180525
IS  - 1471-2415 (Electronic)
IS  - 1471-2415 (Linking)
VI  - 18
IP  - 1
DP  - 2018 May 10
TI  - Prevalence and clinical characteristics of dry eye disease in community-based
      type 2 diabetic patients: the Beixinjing eye study.
PG  - 117
LID - 10.1186/s12886-018-0781-7 [doi]
AB  - BACKGROUND: This study was performed to evaluate the prevalence and clinical
      characteristics of dry eye disease (DED) in community-based type 2 diabetic
      patients and to identify the associated factors related with DED. METHODS: A
      total of 1360 type 2 diabetic patients in the Beixinjing community were randomly 
      selected. All participants were given a questionnaire that assessed basic
      information and subjective symptoms.DED was diagnosed using the revised Japanese 
      DED diagnostic criteria. All subjects underwent a routine ophthalmic examination,
      corneal sensitivity test, tear film break-up time(BUT) test, Schirmer I test,
      fluorescein and lissamine green staining(FL) and fundus photography. Diabetic
      retinopathy (DR) was graded according to the International severity scale of
      diabetic retinopathy and diabetic macular edema. RESULTS: Of the 1360 subjects,
      238 (17.5%) were diagnosed with DED. There was a significant association between 
      the presence of DED and higher blood glucose (P < 0.001, OR1.240) as well as
      higher levels of glycosylated hemoglobin HbA1c (P < 0.001, OR1.108). Corneal
      sensitivity was negatively correlated with the prevalence of DED (P = 0.02,
      OR0.973). CONCLUSIONS: The prevalence of DED in this community-based study was
      17.5%, which was lower than that observed in hospital-based studies. Diabetic
      patients with poor metabolic control were more likely to present with DED. A dry 
      eye examination should be added to the routine screening of diabetes.
FAU - Zou, Xinrong
AU  - Zou X
AD  - Shanghai General Hospital, Nanjing Medical University, No. 100, Haining Road,
      Hongkou District, Shanghai, 200080, China.
AD  - Department of Ophthalmology, Fengcheng Hospital, No.9983, Chuannanfeng Road,
      Fengxian District, Shanghai, 201411, China.
FAU - Lu, Lina
AU  - Lu L
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
FAU - Xu, Yi
AU  - Xu Y
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
FAU - Zhu, Jianfeng
AU  - Zhu J
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
FAU - He, Jiangnan
AU  - He J
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
FAU - Zhang, Bo
AU  - Zhang B
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
FAU - Zou, Haidong
AU  - Zou H
AD  - Shanghai General Hospital, Nanjing Medical University, No. 100, Haining Road,
      Hongkou District, Shanghai, 200080, China. [email protected]
AD  - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and
      Treatment Center, No. 380, Kangding Road, Jingan, Shanghai, 200040, China.
      [email protected]
AD  - Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong
      University, Shanghai, China. [email protected]
AD  - Shanghai Key Laboratory of Fundus Disease, Shanghai, China.
      [email protected]
LA  - eng
GR  - 81670898/Chinese National Nature Science Foundation
GR  - PJ(2012) 0001652/Shanghai Pujiang Program
GR  - SHDC12015315/the Chronic Diseases Prevention and Treatment Project of Shanghai
      Shen Kang Hospital Development Centre
GR  - GWIV-3.3/Shanghai Three Year Public Health Action Program
GR  - GWTD2015S08/Shanghai High-level Oversea Training Team Program on Eye Public
      Health
GR  - 16XD1402300/Shanghai Outstanding Academic Leader Program
PT  - Journal Article
DEP - 20180510
PL  - England
TA  - BMC Ophthalmol
JT  - BMC ophthalmology
JID - 100967802
RN  - TPY09G7XIR (Fluorescein)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Case-Control Studies
MH  - China/epidemiology
MH  - Cornea/metabolism
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/*complications
MH  - Diabetic Retinopathy/epidemiology
MH  - Dry Eye Syndromes/*epidemiology/metabolism/physiopathology
MH  - Female
MH  - Fluorescein/metabolism
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Risk Factors
MH  - Tears/metabolism
PMC - PMC5946388
OTO - NOTNLM
OT  - Community-based
OT  - Dry eye disease
OT  - Prevalence
OT  - Type 2 diabetic patients
EDAT- 2018/05/12 06:00
MHDA- 2018/05/26 06:00
CRDT- 2018/05/12 06:00
PHST- 2017/06/22 00:00 [received]
PHST- 2018/04/30 00:00 [accepted]
PHST- 2018/05/12 06:00 [entrez]
PHST- 2018/05/12 06:00 [pubmed]
PHST- 2018/05/26 06:00 [medline]
AID - 10.1186/s12886-018-0781-7 [doi]
AID - 10.1186/s12886-018-0781-7 [pii]
PST - epublish
SO  - BMC Ophthalmol. 2018 May 10;18(1):117. doi: 10.1186/s12886-018-0781-7.